Phoenix Biotech Acquisition shares and warrants may trade separately starting Friday, the SPAC said. Units not separated will continue to trade on the Nasdaq under PBAXU. Separated shares and warrants are expected to trade under PBAX and PBAXW.
The SPAC raised $155 million last month in an IPO to raise capital for the acquisition of a healthcare or healthcare-related business in the United States or Europe, especially life sciences companies. Read more.
